HHS Scores Early Win In Boehringer's Medicare Pricing Suit

By Hailey Konnath · July 3, 2024, 11:30 PM EDT

A Connecticut federal judge on Wednesday sided with the U.S. Department of Health and Human Services in Boehringer Ingelheim's challenge to a new Medicare drug price negotiation program, rejecting the pharmaceutical...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Boehringer Ingelheim Pharmaceuticals, Inc. v. United States Department of Health and Human Services et al

Case Number

3:23-cv-01103

Court

Connecticut

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

August 18, 2023

Recent Articles By Hailey

July 01, 2024
State AGs Get Stay Lifted In Generic Drug Pricing Litigation
June 27, 2024
OptumRx Agrees To Pay $20M To Resolve DOJ Opioid Claims
June 27, 2024
ACLU Says Mich. Can't Ban Medicaid Coverage Of Abortions
June 18, 2024
Novant Pays $6.7M For Sharing Patient Data With Facebook
June 10, 2024
Baltimore Lands $45M Deal With Allergan In Opioid Litigation
June 07, 2024
Motley Rice Allocated Biggest Share Of $2B Opioid Fees
June 04, 2024
Divided 9th Circ. Reverses Sutter Health Antitrust Trial Victory
May 31, 2024
Caremark Cut Loose From CVS Price-Gouging Case
May 13, 2024
'Grinch' Is Not A Protected Class, HHS Tells 4th Circ.
May 03, 2024
Ala. High Court Won't Rethink Decision On Frozen Embryos